Further, the flu vaccine can reduce systemic inflammation by reducing IL-6 production and downregulating toll-like receptor signaling pathways, Caspases protein, and FAS-associated death domain (FADD) that can adjust the response to SARS-CoV-2 infection and also decrease the COVID-19 burden [35,36]. The gene discussed is IL6; the disease is COVID-19.